Innate Pharma Announces Share and Voting Rights Update

Innate Pharma SA, a biotechnology firm listed on Euronext Paris and Nasdaq, has disclosed its total number of shares and voting rights as of July 3, 2025. The company's outstanding shares total 92,183,523 ordinary shares, supplemented by 6,434 Preferred Shares from 2016 and 7,581 Preferred Shares from 2017. This results in a total of 92,962,943 theoretical voting rights.

Meanwhile, the company reports 92,944,368 exercisable voting rights. These figures are provided in compliance with French regulatory requirements and are essential for stakeholders to monitor shareholding thresholds. The detailed information aims to ensure market transparency and align with recommendations from the Autorité des Marchés Financiers (AMF).